Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 is shown instead of v3.4.2. There are no visible changes to the study information or user actions on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedA site-wide funding/status notice was added, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check48 days agoChange DetectedUpdates are limited to UI and metadata changes: glossary display toggle, updated QC status wording, No FEAR Act Data label, and a new Revision: v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a minor page revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter now shows Revision: v3.3.3, and items referencing HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.2%

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.